Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin

被引：14

作者：

Pérez-Guerrero, C ^{[1
]}

Márquez-Martín, A ^{[1
]}

Herrera, MD ^{[1
]}

Marhuenda, E ^{[1
]}

de Sotomayor, MA ^{[1
]}

机构：

[1] Univ Seville, Fac Pharm, Dept Pharmacol, ES-41012 Seville, Spain

来源：

PHARMACOLOGY | 2005年 / 74卷 / 04期

关键词：

HMG-CoA reductase; simvastatin; calcium; Rho-kinase; spontaneously hypertensive rat;

D O I：

10.1159/000085957

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The acute effect of simvastatin on aortic rings from spontaneously hypertensive rats (SHRs) was identified. Simvastatin-evoked relaxations of both depolarized and phenylephrine-precontracted arteries were independent of the presence of endothelium. This effect was inhibited by diltiazem and mevalonate, but not by the Rho-kinase inhibitor, Y-27632. Simvastatin prevented contraction induced by phenylephrine, calcium ionophore A-23187 and CaCl2 in Ca2+- free medium. Y-27632 decreased the effect of simvastatin. On the contrary, contraction induced by noradrenaline in Ca2+- free medium was not affected. These results suggest that simvastatin elicited an effect on vascular smooth muscle cells from SHRs that may involve blockade of extracellular calcium entry and decrease vascular contraction by affecting Rho-kinase. Copyright (C) 2005 S. Karger AG, Basel.

引用

页码：209 / 215

页数：7

共 50 条

[31] DISPOSITION OF FLUVASTATIN, AN INHIBITOR OF HMG-COA REDUCTASE, IN MOUSE, RAT, DOG, AND MONKEY
TSE, FLS
SMITH, HT
BALLARD, FH
NICOLETTI, J
BIOPHARMACEUTICS & DRUG DISPOSITION, 1990, 11 (06) : 519 - 531
[32] Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: Beneficial or detrimental?
Katsiki, Niki
Tziomalos, Konstantinos
Chatzizisis, Yiannis
Elisaf, Moses
Hatzitolios, Apostolos I.
ATHEROSCLEROSIS, 2010, 211 (01) : 9 - 14
[33] HMG-CoA reductase inhibitorsNasal polyps (first report with atorvastatin and simvastatin): 3 case reports
Reactions Weekly, 2005, 1047 (1) : 10 - 11
[34] Simvastatin, an HMG-CoA reductase inhibitor induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes
Bonn, V
Cheung, RC
Chen, B
Taghibiglou, C
Van Iderstine, SC
Adeli, K
ATHEROSCLEROSIS, 2002, 163 (01) : 59 - 68
[35] HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer's-associated markers
Salari, Adel
Roghani, Mehrdad
Khalili, Mohsen
METABOLIC BRAIN DISEASE, 2024, 40 (01)
[36] Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase
Pak, Valeriy V.
Koo, Minseon
Yun, Lyubov
Kwon, Dae Young
JOURNAL OF MOLECULAR RECOGNITION, 2007, 20 (03) : 197 - 203
[37] Design of a highly potent inhibitory peptide acting as a competitive inhibitor of HMG-CoA reductase
Valeriy V. Pak
Minseon Koo
Dae Young Kwon
Lyubov Yun
Amino Acids, 2012, 43 : 2015 - 2025
[38] Design of a highly potent inhibitory peptide acting as a competitive inhibitor of HMG-CoA reductase
Pak, Valeriy V.
Koo, Minseon
Kwon, Dae Young
Yun, Lyubov
AMINO ACIDS, 2012, 43 (05) : 2015 - 2025
[39] Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG-CoA reductase
Pak, Valeriy V.
Koo, Minseon
Kim, Min Jung
Yang, Hye Jeong
Yun, Lyubov
Kwon, Dae Young
JOURNAL OF MOLECULAR RECOGNITION, 2008, 21 (04) : 224 - 232
[40] Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait
Iqbal, Danish
Khan, M. Salman
Khan, Mohd Sajid
Ahmad, Saheem
Hussain, Md Sarfaraj
Ali, Mohd
LIPIDS IN HEALTH AND DISEASE, 2015, 14

← 1 2 3 4 5 →